Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CyBio is a leading provider of laboratory automation and liquid handling solutions, primarily serving the pharmaceutical, biotechnology, and academic research sectors. Founded in 1990 as a spin-off from Jenoptik (originally Jenoptik Bioinstruments), the company specializes in high-precision pipetting, plate handling, and automated screening systems. Its flagship products include the CyBio FeliX flexible liquid handling platform and the CyBi-Well automated pipettor, which are used for applications such as drug discovery, genomics, and cell-based assays. In 2014, CyBio was fully merged into Analytik Jena AG, where it continues to operate as a core product brand within the Life Science business unit. The company is headquartered in Jena, Germany, and maintains a global presence through its parent company's network.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CyBio.